Efficacy and Safety of Osilodrostat in Managing Cushing’s Syndrome: A Systematic Review and Meta-Analysis
No meta-analysis has holistically analysed and summarized the efficacy and safety of osilodrostat, a novel dual 11β-hydroxylase (cytochrome P450 family 11 subfamily B member 1 [CYP11B1]) and 18-hydroxylase (aldosterone synthase, CYP11B2) inhibitor in managing Cushing’s syndrome (CS). We undertook th...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Medknow Publications
2024-06-01
|
| Seri Bilgileri: | Indian Journal of Endocrinology and Metabolism |
| Konular: | |
| Online Erişim: | https://journals.lww.com/10.4103/ijem.ijem_260_23 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|